Telomere dysfunction causes alveolar stem cell failure
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Significance: Idiopathic pulmonary fibrosis and emphysema are leading causes of mortality, but there are no effective therapies. Mutations in telomerase are the most common identifiable risk factor for idiopathic pulmonary fibrosis. They also predispose to severe emphysema in smokers, occurring at a frequency similar to α-1 antitrypsin deficiency. The work shown here points to alveolar stem cell senescence as a driver of these pathologies. Epithelial stem cell failure was associated with secondary inflammatory recruitment and exquisite susceptibility to injury from “second hits.” The findings suggest that efforts to reverse the stem cell failure state directly, rather than its secondary consequences, may be an effective therapy approach in telomere-mediated lung disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Telomere dysfunction, specifically induced in alveolar epithelial type II cells through the deletion of the telomere proteins TRF1 or TRF2, led to impaired regeneration, inflammation and fibrosis61,62.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [62]
In the citing paper
“Increased telomere shortening in aging diminishes AEC1 regeneration by AEC2s (83, 84).”
From Aging and Lung Disease (2020) · cites this paper as [84]
Citations
Cites
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
Macrophage migration inhibitory factor: a regulator of innate immunity
Calandra, T., & Roger, T. (2003) · Nature Reviews Immunology · doi:10.1038/nri1200 · Cited by 1,795
Type 2 alveolar cells are stem cells in adult lung
Barkauskas, C. E., Cronce, M. J., Rackley, C. R., Bowie, E. J., Keene, D. R., Stripp, B. R., Randell, S. H., Noble, P. W., & Hogan, B. L. M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68782 · Cited by 1,776 · cited 1×
“These structures are comprised exclusively of AEC2s that have both self-renewed and differentiated into type 1 alveolar epithelial cells (AEC1s) (14).”
BackgroundSelf-citationTelomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357 · cited 2×
“Am J Respir Crit Care Med 174(8):886–893.”
Self-citationLongevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
Rudolph, K. L., Chang, S., Lee, H.-W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80580-2 · Cited by 1,349 · cited 1×
“In high-turnover epithelial tissues such as the intestinal tract, telomere dysfunction preferentially induces apoptosis (32, 33, 38).”
BackgroundEssential role of mouse telomerase in highly proliferative organs
Lee, H.-W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., Greider, C. W., & DePinho, R. A. (1998) · Nature · doi:10.1038/33345 · Cited by 1,270 · cited 1×
“In high-turnover epithelial tissues such as the intestinal tract, telomere dysfunction preferentially induces apoptosis (32, 33, 38).”
Backgroundp53- and ATM-Dependent Apoptosis Induced by Telomeres Lacking TRF2
Karlseder, J., Broccoli, D., Dai, Y., Hardy, S., & de Lange, T. (1999) · Science · doi:10.1126/science.283.5406.1321 · Cited by 1,086
Alveolar progenitor and stem cells in lung development, renewal and cancer
Desai, T. J., Brownfield, D. G., & Krasnow, M. A. (2014) · Nature · doi:10.1038/nature12930 · Cited by 1,060
Rock, J. R., Barkauskas, C. E., Cronce, M. J., Xue, Y., Harris, J. R., Liang, J., Noble, P. W., & Hogan, B. L. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117988108 · Cited by 1,030
Self-citationChin, L., Artandi, S. E., Shen, Q., Tam, A., Lee, S.-L., Gottlieb, G. J., Greider, C. W., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80762-x · Cited by 979
Hogan, B. L. M., Barkauskas, C. E., Chapman, H. A., Epstein, J. A., Jain, R., Hsia, C. C. W., Niklason, L., Calle, E., Le, A., Randell, S. H., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.07.012 · Cited by 876
Self-citationHow Telomeres Solve the End-Protection Problem
de Lange, T. (2009) · Science · doi:10.1126/science.1170633 · Cited by 826 · cited 2×
“For an in vivo system, we generated a model in which telomere dysfunction can be induced by deleting telomeric repeat-binding factor 2 (Trf2) (19, 20) exclusively in adult AEC2s.”
BackgroundMethodImmunologic Aspects of Chronic Obstructive Pulmonary Disease
Cosio, M. G., Saetta, M., & Agusti, A. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804752 · Cited by 815 · cited 2×
“Although more work is needed to characterize the immune responses driven by epithelial senescence, it is noteworthy that the macrophage and T-cell predominance of the infiltrates recapitulate those seen in cigarette smoke-induced lung disease (23).”
BackgroundResultShort telomeres are a risk factor for idiopathic pulmonary fibrosis
Alder, J. K., Chen, J. J.-L., Lancaster, L., Danoff, S., Su, S.-C., Cogan, J. D., Vulto, I., Xie, M., Qi, X., Tuder, R. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804280105 · Cited by 805 · cited 3×
“Proc Natl Acad Sci USA 100(6):3251–3256.”
BackgroundSelf-citationThomas, A. Q., Lane, K., Phillips, J., Prince, M., Markin, C., Speer, M., Schwartz, D. A., Gaddipati, R., Marney, A., Johnson, J., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200112-123oc · Cited by 641
DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion
Celli, G. B., & de Lange, T. (2005) · Nature Cell Biology · doi:10.1038/ncb1275 · Cited by 623 · cited 2×
“For an in vivo system, we generated a model in which telomere dysfunction can be induced by deleting telomeric repeat-binding factor 2 (Trf2) (19, 20) exclusively in adult AEC2s.”
BackgroundMethodPulmonary fibrosis: patterns and perpetrators
Noble, P. W., Barkauskas, C. E., & Jiang, D. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60323 · Cited by 595 · cited 1×
“The alveolar structures are preferentially affected in these disorders, and their pathology is marked by inflammation and mesenchymal abnormalities (3, 4).”
BackgroundSelf-citationAlveolar Cell Senescence in Patients with Pulmonary Emphysema
Tsuji, T., Aoshiba, K., & Nagai, A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1374oc · Cited by 527 · cited 2×
“Dysfunctional telomeres and biomarkers of senescence have been well documented in alveolar epithelial cells from diseased human lungs (6, 13).”
BackgroundPathogenesis of chronic obstructive pulmonary disease
Tuder, R. M., & Petrache, I. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60324 · Cited by 433
Self-citationTelomere Lengths, Pulmonary Fibrosis and Telomerase (TERT) Mutations
Diaz de Leon, A., Cronkhite, J. T., Katzenstein, A.-L. A., Godwin, J. D., Raghu, G., Glazer, C. S., Rosenblatt, R. L., Girod, C. E., Garrity, E. R., Xing, C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010680 · Cited by 377
Telomeres and age-related disease: how telomere biology informs clinical paradigms
Armanios, M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66370 · Cited by 347 · cited 7×
“Clinically, this molecular abnormality manifests in a spectrum of telomere syndromes that recapitulate features of age-associated pathology (1).”
BackgroundMethodInfluentialSelf-citationCoppé, J.-P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P.-Y., & Campisi, J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060301 · Cited by 302 · cited 1×
“Telomere-mediated senescence has been associated with altered gene expression as well as an in vitro secretory phenotype (known as “SASP”) in cultured human cells (39, 40).”
BackgroundShort Telomeres, even in the Presence of Telomerase, Limit Tissue Renewal Capacity
Hao, L.-Y., Armanios, M., Strong, M. A., Karim, B., Feldser, D. M., Huso, D., & Greider, C. W. (2005) · Cell · doi:10.1016/j.cell.2005.11.020 · Cited by 302
Self-citationTelomere Length Is a Determinant of Emphysema Susceptibility
Alder, J. K., Guo, N., Kembou, F., Parry, E. M., Anderson, C. J., Gorgy, A. I., Walsh, M. F., Sussan, T., Biswal, S., Mitzner, W., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0520oc · Cited by 265 · cited 6×
“Notably, although the baseline proliferation rate in tamoxifen-treated mice was higher than we had documented previously in tamoxifenfree mice (7), the proliferation in AEC2s with dysfunctional telomeres was significantly blunted (Fig.”
BackgroundInfluentialSelf-citationShort Telomeres are Sufficient to Cause the Degenerative Defects Associated with Aging
Armanios, M., Alder, J. K., Parry, E. M., Karim, B., Strong, M. A., & Greider, C. W. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.10.028 · Cited by 257 · cited 1×
“Proc Natl Acad Sci USA 105(35):13051–13056.”
Self-citationTelomerase and idiopathic pulmonary fibrosis
Armanios, M. (2012) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.10.013 · Cited by 245
Self-citationWild-derived inbred mouse strains have short telomeres
Hemann, M. T. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.22.4474 · Cited by 228 · cited 2×
“One hurdle to modeling the consequences of telomere dysfunction in a cell type-specific manner is that laboratory mice have very long telomeres (17).”
BackgroundZhang, H., Pan, K.-H., & Cohen, S. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2627983100 · Cited by 209 · cited 1×
“Telomere-mediated senescence has been associated with altered gene expression as well as an in vitro secretory phenotype (known as “SASP”) in cultured human cells (39, 40).”
BackgroundTelomerase mutations in smokers with severe emphysema
Stanley, S. E., Chen, J. J. L., Podlevsky, J. D., Alder, J. K., Hansel, N. N., Mathias, R. A., Qi, X., Rafaels, N. M., Wise, R. A., Silverman, E. K., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78554 · Cited by 196 · cited 1×
“Idiopathic pulmonary fibrosis and emphysema are the most prevalent clinical manifestations of human telomere syndromes and account for more than 80% of presentations (1, 2).”
BackgroundSelf-citationParry, E. M., Alder, J. K., Qi, X., Chen, J. J.-L., & Armanios, M. (2011) · Blood · doi:10.1182/blood-2010-11-322149 · Cited by 194 · cited 1×
“Human telomere-mediated lung disease similarly represents an attenuated clinical phenotype that becomes symptomatic in late adulthood, on average four decades later than bone marrow failure, reflecting a more slowly evolving process (36).”
BackgroundSelf-citationDietz, A. C., Orchard, P. J., Baker, K. S., Giller, R. H., Savage, S. A., Alter, B. P., & Tolar, J. (2011) · Bone Marrow Transplantation · doi:10.1038/bmt.2010.65 · Cited by 151 · cited 1×
“We chose this model because patients with telomere syndrome are exquisitely susceptible to pulmonary-toxic drugs, such as bleomycin and busuflan, (1, 28).”
MethodIdiopathic Pulmonary Fibrosis: A Disorder of Epithelial Cell Dysfunction
Zoz, D. F., Lawson, W. E., & Blackwell, T. S. (2011) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31821a9d8e · Cited by 133 · cited 1×
“Am J Respir Crit Care Med 165(9):1322–1328.”
De La Fuente, J., & Dokal, I. (2007) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2007.00721.x · Cited by 119 · cited 1×
“Affected patients are also exquisitely sensitive to pulmonary-toxic drugs, which are fatal even when there is no detectable baseline lung disease (1, 5).”
BackgroundLazzerini Denchi, E., Celli, G., & de Lange, T. (2006) · Genes & Development · doi:10.1101/gad.1453606 · Cited by 116
The gastrointestinal manifestations of telomere‐mediated disease
Jonassaint, N. L., Guo, N., Califano, J. A., Montgomery, E. A., & Armanios, M. (2013) · Aging Cell · doi:10.1111/acel.12041 · Cited by 107 · cited 1×
“In high-turnover epithelial tissues such as the intestinal tract, telomere dysfunction preferentially induces apoptosis (32, 33, 38).”
BackgroundSelf-citationShort Telomeres Compromise β-Cell Signaling and Survival
Guo, N., Parry, E. M., Li, L.-S., Kembou, F., Lauder, N., Hussain, M. A., Berggren, P.-O., & Armanios, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017858 · Cited by 100
Self-citationLazzerini Denchi, E., Celli, G., & de Lange, T. (2021) · Genes & Development · doi:10.1101/gad.349030.121 · Cited by 99
Combined pulmonary fibrosis and emphysema syndrome associated with familial SFTPC mutation
Cottin, V., Reix, P., Khouatra, C., Thivolet-Béjui, F., Feldmann, D., & Cordier, J. F. (2011) · Thorax · doi:10.1136/thx.2010.151407 · Cited by 95
IL-17C Is a Mediator of Respiratory Epithelial Innate Immune Response
Pfeifer, P., Voss, M., Wonnenberg, B., Hellberg, J., Seiler, F., Lepper, P. M., Bischoff, M., Langer, F., Schäfers, H., Menger, M. D., et al. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0232oc · Cited by 75
Verbist, K. C., Cole, C. J., Field, M. B., & Klonowski, K. D. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002613 · Cited by 64
Macrophage Migration Inhibitory Factor Is a Novel Determinant of Cigarette Smoke–Induced Lung Damage
Fallica, J., Boyer, L., Kim, B., Serebreni, L., Varela, L., Hamdan, O., Wang, L., Simms, T. M., Damarla, M., Kolb, T. M., et al. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0371oc · Cited by 45
Self-citation
Cited by
Blackburn, E. H., Epel, E. S., & Lin, J. (2015) · Science · doi:10.1126/science.aab3389 · Cited by 1,596
Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis
Moss, B. J., Ryter, S. W., & Rosas, I. O. (2022) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-042320-030240 · Cited by 821
Biomarkers, oxidative stress and autophagy in skin aging
Gu, Y., Han, J., Jiang, C., & Zhang, Y. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101036 · Cited by 762
Telomere dysfunction in ageing and age-related diseases
Rossiello, F., Jurk, D., Passos, J. F., & d’Adda di Fagagna, F. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00842-x · Cited by 754
An atlas of the aging lung mapped by single cell transcriptomics and deep tissue proteomics
Angelidis, I., Simon, L. M., Fernandez, I. E., Strunz, M., Mayr, C. H., Greiffo, F. R., Tsitsiridis, G., Ansari, M., Graf, E., Strom, T.-M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08831-9 · Cited by 637
Metadata
- Authors
- Alder, J. K., Barkauskas, C. E., Limjunyawong, N., Stanley, S. E., Kembou, F., Tuder, R. M., Hogan, B. L. M., Mitzner, W., & Armanios, M.
- Affiliations
- Sidney Kimmel Comprehensive Cancer Center (US)
- Departments of cMedicine and
- Johns Hopkins University (US)
- University of Colorado Anschutz (US)
- Duke University (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2015-04-03
- Volume
- 112
- Issue
- 16
- Pages
- 5099-5104
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC4413294
- OpenAlex
- W1967991223
- Cited by
- 339
- References
- 41
- Citations by year
- 2026: 17 · 2025: 31 · 2024: 19 · 2023: 24 · 2022: 36 · 2021: 47 · 2020: 34 · 2019: 33 · 2018: 29 · 2017: 33 · 2016: 18 · 2015: 18
- FWCI
- 24.07
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- HHS | National Institutes of Health (K99 HL113105, K08 HL122521, PO1 HL10342, R21 HL104345, RO1 HL119476)
- Ellison Medical Foundation (NA)
- Flight Attendant Medical Research Institute (NA)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Neonatal Respiratory Health Research
- Keywords
- telomere dysfunction, alveolar stem cells, alveolar type II cells, cellular senescence, shelterin, alveolar organoids, lung regeneration, bleomycin-induced lung injury, lung inflammation, idiopathic pulmonary fibrosis, emphysema, alveolar repair
- MeSH terms
- Aging, Animals, Cell Differentiation, Epithelial Cells, Immunity, Inflammation, Mesoderm, Peptides, Pulmonary Alveoli, Stem Cells, Signal Transduction, Tumor Suppressor Protein p53, Telomere, Stromal Cells, Gene Deletion, Spheroids, Cellular, Paracrine Communication, Telomeric Repeat Binding Protein 2, Intercellular Signaling Peptides and Proteins, Pulmonary Surfactant-Associated Protein C, Cell Proliferation, Mice, Telomere Shortening
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.